Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Portable EEG to triage suspected stroke patients in ambulances

Official title: Clinical Evaluation of Pre-hospital Stroke Triage Devices - Electroencephalography

Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT06871969 · Data updated 2026-11-12

This trial will test whether a portable dry‑electrode EEG headset (StrokePointer) can detect large vessel occlusion strokes in adults with suspected acute stroke so ambulance crews can take them directly to hospitals that perform thrombectomy.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment275 (estimated)
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academic / other
Locations1 site (Amsterdam, North Holland)
StatusRecruiting
StartedJuly 1, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedOctober 3, 2025
Trial IDNCT06871969 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with suspected acute stroke identified by ambulance personnel within 24 hours of symptom onset (or last seen well) who can provide informed or deferred consent are the intended participants.

Probably not a fit

Patients with scalp injuries or infections at the headset site, those with very poor EEG signal quality, or patients with stroke onset beyond 24 hours are unlikely to benefit from this device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study will deploy a portable dry‑electrode EEG device (StrokePointer) in the prehospital ambulance setting to record brain signals from adults with suspected acute stroke and analyze those signals on site. Recordings will be attempted within 24 hours of symptom onset and interpreted by the device algorithm, with device results compared to hospital imaging and final clinical diagnosis to determine accuracy. The trial aims to demonstrate that the device can produce analyzable EEG in >85% of patients and achieve diagnostic accuracy for LVO detection with an AUC >0.8. Safety and feasibility of using the headset in the ambulance and consent procedures (including deferred consent) are also assessed at a single academic center.

Why it matters

Potential benefit: If successful, the device could let ambulance crews identify likely LVO strokes earlier and route patients directly to thrombectomy centers, shortening time-to-treatment and potentially improving outcomes.

How similar studies have gone: Previous dry‑electrode EEG approaches have shown promising diagnostic accuracy for LVO detection (reported AUC ≈ 0.91) but experienced poor signal quality in about one‑third of patients, so the approach is promising but needs validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Suspected acute stroke as per judgement of the ambulance personnel.
* Age 18 years or older.
* Onset of symptoms (or last seen well) \<24 hours.
* Written informed consent by patient or legal representative (deferred).

Exclusion Criteria:

\- Injuries or infections of the scalp in the area of the electrode headset placement.

Where it's running

  • Amsterdam University Medical Centers, location AMC
    Amsterdam, North Holland, Netherlands
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Evaluating the impact of artery calcification on stroke treatment outcomes

    This study is trying to see if the amount of calcium in the arteries affects how well stroke patients do after a specific treatment for blocked blood vessels.

    Recruiting Zhujiang Hospital · Guangzhou, Guangdong · NCT06418698

  • Intra-arterial clot-dissolving treatment for medium-vessel ischemic stroke

    The team will test whether giving tenecteplase directly into the artery helps adults with acute ischemic stroke caused by medium-vessel blockage or severe narrowing.

    Recruiting at 6 sites The Second Hospital of Anhui Medical University · Fuyang, Anhui and 5 other locations · NCT07185022

  • Endovascular treatment for stroke beyond 24 hours

    This study is testing whether a specific stroke treatment can help people who have had a stroke more than 24 hours ago feel better and regain independence compared to just receiving standard care.

    Recruiting The Second Hospital of Anhui Medical University · Hefei, Anhui · NCT06959199

  • Heart assessment to check repeat-stroke risk in people with atrial fibrillation

    This project will test whether detailed heart examinations can find which people with atrial fibrillation who just had an ischemic stroke are at high risk of having another stroke.

    Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT06954610

  • Remote ischemic conditioning after aneurysm clipping for ruptured brain aneurysms

    This test tries brief cycles of limb cuff inflation (remote ischemic conditioning) to see if it is safe and helps recovery in adults after surgical clipping of a ruptured brain aneurysm (aneurysmal subarachnoid hemorrhage).

    Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT06819657

  • Video call assessment for suspected stroke

    This study tests if using video calls between neurologists and emergency responders can help quickly and accurately assess patients who might be having a stroke.

    Recruiting University of Southern Denmark · Aabenraa, Region Syddanmark · NCT06570681

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.